Historique
Article de Périodique
Shifts in cannabis use at the onset of the COVID-19 pandemic among Global Drug Survey respondents from 13 countries (2023)
Auteur(s) :
PULJEVIC, C. ;
COSSART, A. ;
DAVIES, E. L. ;
BARRATT, M. J. ;
MAIER, L. J. ;
JAUFFRET-ROUSTIDE, M. ;
WINSTOCK, A. R. ;
FERRIS, J. A.
Année :
2023
Page(s) :
145-161
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
CANNABIS
;
EPIDEMIE
;
SANTE MENTALE
;
USAGER
;
EVOLUTION
;
PREVALENCE
;
COMPARAISON
;
SANTE
;
PLAISIR
;
PERFORMANCE
;
AUTOEVALUATION
Autres mots-clés
Résumé :
Purpose: The COVID-19 pandemic likely impacted cannabis distribution, access and usage worldwide. This study aims to describe self-reported changes in cannabis use and related outcomes following COVID-19-related restrictions among an international sample of people who use drugs.
Design/methodology/approach: Using data from the Global Drug Survey COVID-19 Special Edition, the authors identified 20,417 respondents from 13 countries who reported whether the number of THC-containing cannabis usage days changed compared with February 2020 (before COVID-19 restrictions). Using descriptive statistics and a multinomial multivariable logistic regression, the authors investigated the impact of changes in cannabis use on respondents’ mental health, physical health, relationships, finances, work/study performance and cannabis-related pleasure/enjoyment.
Findings: Similar proportions of respondents reported that their cannabis use had stayed the same (38.2%) or increased (38.3%) compared with February 2020, while 21.9% of respondents reported a decrease. The most common reason for increased use was having more time (68.4%), while decreased use was associated with having less contact with people they use cannabis with (58.4%). The likelihood of reporting worse mental and physical health, finances, and work/study performance following COVID-19 restrictions was highest among those who reported increased cannabis use.
Research limitations/implications: These findings provide a unique understanding of the short-term international impact of initial COVID-19 restrictions on cannabis use, and highlight the need for policy to address the ongoing and improved provision of evidence-based mental health and other support for people who frequently use cannabis.
Originality/value: To the best of the authors' knowledge, this is the world’s largest international study exploring the impacts of these changes in cannabis use following initial COVID-19 restrictions on individuals' mental health, physical health, relationships, finances, work/study performance and cannabis-related pleasure. This study is also unique in comparing these changes across multiple continents.
Design/methodology/approach: Using data from the Global Drug Survey COVID-19 Special Edition, the authors identified 20,417 respondents from 13 countries who reported whether the number of THC-containing cannabis usage days changed compared with February 2020 (before COVID-19 restrictions). Using descriptive statistics and a multinomial multivariable logistic regression, the authors investigated the impact of changes in cannabis use on respondents’ mental health, physical health, relationships, finances, work/study performance and cannabis-related pleasure/enjoyment.
Findings: Similar proportions of respondents reported that their cannabis use had stayed the same (38.2%) or increased (38.3%) compared with February 2020, while 21.9% of respondents reported a decrease. The most common reason for increased use was having more time (68.4%), while decreased use was associated with having less contact with people they use cannabis with (58.4%). The likelihood of reporting worse mental and physical health, finances, and work/study performance following COVID-19 restrictions was highest among those who reported increased cannabis use.
Research limitations/implications: These findings provide a unique understanding of the short-term international impact of initial COVID-19 restrictions on cannabis use, and highlight the need for policy to address the ongoing and improved provision of evidence-based mental health and other support for people who frequently use cannabis.
Originality/value: To the best of the authors' knowledge, this is the world’s largest international study exploring the impacts of these changes in cannabis use following initial COVID-19 restrictions on individuals' mental health, physical health, relationships, finances, work/study performance and cannabis-related pleasure. This study is also unique in comparing these changes across multiple continents.
Affiliation :
Centre for Health Services Research, The University of Queensland, Brisbane, Australia and School of Public Health, The University of Queensland, Brisbane, Australia
Centre for Psychological Research, Oxford Brookes University, Oxford, UK
Social and Global Studies Centre, RMIT University, Melbourne, Australia and National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
Department of Clinical Pharmacology, University of California San Francisco, San Francisco, California, USA
Centre dÉtude des Mouvements Sociaux, Paris, France; Baldy Center for Law and Social Policy, Buffalo University, Buffalo, New York, USA; British Columbia Center On Substance Use, Vancouver, Canada
University College London, London, UK and Global Drug Survey Ltd, London, UK
Centre for Psychological Research, Oxford Brookes University, Oxford, UK
Social and Global Studies Centre, RMIT University, Melbourne, Australia and National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Australia
Department of Clinical Pharmacology, University of California San Francisco, San Francisco, California, USA
Centre dÉtude des Mouvements Sociaux, Paris, France; Baldy Center for Law and Social Policy, Buffalo University, Buffalo, New York, USA; British Columbia Center On Substance Use, Vancouver, Canada
University College London, London, UK and Global Drug Survey Ltd, London, UK
Cote :
Abonnement